Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 21, 2026, 4:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–27 of 3 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Adult Meningeal Hemangiopericytoma Clear all

Completed Phase 1 Interventional

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

NCT00784914

View directory record Official record

Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer
Interventions: temsirolimus, pharmacological study, cytokine levels; Drug · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older

Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Duarte, California

Source: ClinicalTrials.gov public record

Updated Apr 16, 2018 · Synced May 21, 2026, 4:40 PM EDT

Completed Phase 3 Interventional Results available

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

NCT00538850

View directory record Official record

Conditions: Cancer
Interventions: Fentanyl sublingual spray, Placebo; Drug
Lead sponsor: INSYS Therapeutics Inc; Industry
Eligibility: 18 Years and older

Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Chandler, Arizona

Source: ClinicalTrials.gov public record

Updated Mar 4, 2014 · Synced May 21, 2026, 4:40 PM EDT

Completed Phase 2 Interventional Results available

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

NCT00045734

View directory record Official record

Conditions: Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Grade III Meningioma, Adult Meningeal Hemangiopericytoma, Adult Meningioma, Recurrent Adult Brain Tumor
Interventions: imatinib mesylate, laboratory biomarker analysis, pharmacological study; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older

Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 7
States / cities: Los Angeles, California • San Francisco, California • Bethesda, Maryland + 4 more

Source: ClinicalTrials.gov public record

Updated May 14, 2017 · Synced May 21, 2026, 4:40 PM EDT